Celldex Therapeutics Inc (CLDX) Volatility Spurs A Quest For Clarity
Currently, there are 66.38M common shares owned by the public and among those 64.51M shares have been available to trade. The company’s stock has a 5-day price change of -0.49% and -4.59% over the past three months. CLDX shares are trading -19.47% year to date (YTD), with the 12-month market performance down to -45.98% lower. […]
Celldex Therapeutics Inc. (NASDAQ: CLDX): Hunting Genuine Value In Market Debris
Wellington Management Co. LLP recently announced the acquisition of new stake in Celldex Therapeutics Inc. (NASDAQ:CLDX). The institutional investor has increased its shareholding in the Healthcare company by 5.85% to 5.43 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 9.93% valued currently at $164.1 million. In addition, […]